| Protocol | Primary Receptor Targets | Typical Dose Range | Peak Plasma Time | Common Adverse Events (Incidence) | Recommended Spacing | Bottom Line Assessment | ||||||| | Melanotan-2 Monotherapy | MC1R, MC3R, MC4R, MC5R (non-selective) | 5001000 mcg subcutaneous | 12 hours | Nausea (4060%), flushing (3050%), hyperpigmentation (90%+), spontaneous erections (males, 2040%) | Daily or alternate days
It is derived from a protective protein found naturally in human gastric juice, which contributes to gut mucosal integrity and tissue repair
Es estable, seguro y adecuado para aplicaciones tales como los sueros, cremas, mscaras y anti-envejecimiento de las soluciones
Pain that radiates through to your back
Real-world safety data from compounded GLP-1 users mirrors findings from branded formulations: most adverse events are mild to moderate gastrointestinal effects